The Company’s key objective is to develop and market new products for Autism and other related neurodevelopmental conditions where there is unmet medical need.
Neuropharm is working in collaboration with clinical investigators, scientists, manufacturers and patient advocacy networks in the United States of America and Europe to deliver advanced solutions for the management or treatment of CNS disorders.

Our lead products are for the treatment or management of Autism and Fragile X syndrome.

Effective & Clinically Preferred Solutions

Neuropharm seeks to identify and rapidly validate effective solutions to address target neurodevelopmental indications and aims to improve patient diagnosis, compliance, safety and ease of use by using the most up to date and appropriate technology platforms.

Empowering Patients, Families & Practitioners

Neuropharm works closely with clinicians, families and patients, as partner of choice for the development of cost effective, tailored diagnostic and treatment solutions for niche or orphan CNS disorders.

Making a Real Difference to Quality of Life

Neuropharm develops products that will make substantial improvements to the quality of life for patients and their carers, while bringing economic benefits for healthcare providers.

Unique Products & Brands for Special Patients

Neuropharm works alongside specialist partners with expertise and intellectual property in diagnostics, drug delivery technology and manufacturing processes to optimize each product, recognizing the importance of patent and brand protection for its products.

Available to Patients Internationally

Neuropharm works closely with regulators to ensure that its products are developed, validated and manufactured under appropriate conditions to meet international regulatory requirements.

A Glimpse into the Future

Neuropharm is collaborating with researchers to translate the rapidly advancing knowledge of neurobiology into clinical practice, gaining unique insights. These insights can help identify novel biomarkers and potential medicines that may aid in understanding, treating or modifying the underlying basis of disease.